Julian Upton

Sameer Lal and Sandeep Gantotti discuss the building of a next-gen medical information practice to modernize its operations and unlock its value to the wider organization and to HCPs.

Industry’s tardy shift to cloud-based solutions looks set to gather pace in 2021.

Looking back at 1981.

Kevin Foust, Senior Director of Research & Early Development at Novartis Gene Therapies, talks to Pharm Exec about his involvement in the development of Zolgensma, the first and only gene therapy approved to treat spinal muscular atrophy (SMA).